Company profile SBFM

Sunshine Biopharma Inc
sunshine biopharma inc (sbfm) is a pharmaceuticals company based out of 469 jean-talon west, 3rd floor, montreal, québec, canada.
Quarter analysis & expected interest

There is not enough data for Sunshine Biopharma drug manufacturers to provide analysis

Correlation between past revenue and Sunshine Biopharma drug manufacturers search interest

There is not enough data for Sunshine Biopharma drug manufacturers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Sunshine Biopharma drug manufacturers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 01:40:00.

After 38 days of this quarter the interest is at 14.0. Based on that we can calculate that during remaining 53 days it will total up to 34.0.
Sunshine Biopharma stock expected interest is significantly lower compared to previous quarter (-57.5%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201932
44
37.5% QoQ
29
-34.1% QoQ
126
334.5% QoQ
2020 138
331.2% YoY 9.5% QoQ
118
168.2% YoY -14.5% QoQ
144
396.6% YoY 22.0% QoQ
133
5.6% YoY -7.6% QoQ
2021 170
23.2% YoY 27.8% QoQ
67
-43.2% YoY -60.6% QoQ
75
-47.9% YoY 11.9% QoQ
174
30.8% YoY 132.0% QoQ
2022 96
-43.5% YoY -44.8% QoQ
276
311.9% YoY 187.5% QoQ
15
-80.0% YoY -94.6% QoQ
106
-39.1% YoY 606.7% QoQ
2023 31
-67.7% YoY -70.8% QoQ
63
-77.2% YoY 103.2% QoQ
69
360.0% YoY 9.5% QoQ
80
-24.5% YoY 15.9% QoQ
2024 14
-54.8% YoY -82.5% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Sunshine Biopharma stock search interestLast update: February 08 2024 01:40:00.
Correlation coefficient between keyword and revenue is 0.48
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 01:40:01.

The average 5 years interest of Sunshine Biopharma stock was 7.66 per week.
The last year interest of Sunshine Biopharma stock compared to the last 5 years has changed by -38.25%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -24.08%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Sunshine Biopharma research and development to provide analysis

Correlation between past revenue and Sunshine Biopharma research and development search interest

There is not enough data for Sunshine Biopharma research and development to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Sunshine Biopharma research and development to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Adva-27a cancer treatment to provide analysis

Correlation between past revenue and Adva-27a cancer treatment search interest

There is not enough data for Adva-27a cancer treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Adva-27a cancer treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for SBFM-PL4 anti-coronavirus treatment to provide analysis

Correlation between past revenue and SBFM-PL4 anti-coronavirus treatment search interest

There is not enough data for SBFM-PL4 anti-coronavirus treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for SBFM-PL4 anti-coronavirus treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for K1.1 mRNA anti-cancer agents to provide analysis

Correlation between past revenue and K1.1 mRNA anti-cancer agents search interest

There is not enough data for K1.1 mRNA anti-cancer agents to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for K1.1 mRNA anti-cancer agents to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Essential 9 amino acids capsules to provide analysis

Correlation between past revenue and Essential 9 amino acids capsules search interest

There is not enough data for Essential 9 amino acids capsules to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Essential 9 amino acids capsules to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Essential Calcium-Vitamin D supplement to provide analysis

Correlation between past revenue and Essential Calcium-Vitamin D supplement search interest

There is not enough data for Essential Calcium-Vitamin D supplement to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Essential Calcium-Vitamin D supplement to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for SBFM
Earnings date: 2024-04-03 Before open
Company name: Sunshine Biopharma Inc
Sector: Professional, Scientific, and Technical Services
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-04-06T12:30:00Z

AccessWire
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year

2025-10-28T18:10:00Z

AccessWire
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

2025-10-28T11:45:00Z

AccessWire
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

2025-10-20T11:45:00Z

AccessWire
Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

2025-10-16T11:45:00Z

AccessWire
Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin

2025-10-14T14:45:00Z

AccessWire
Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)

2025-10-14T12:50:00Z

AccessWire
Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)

2025-10-14T11:00:00Z

AccessWire
Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience

2025-10-09T12:00:00Z

AccessWire
Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

2025-10-08T16:46:37Z

Analyst Upgrades
Aegis Capital Reiterates Buy on Sunshine Biopharma, Maintains $7 Price Target

2025-09-30T16:05:35-04:00

SEC
8-K Form - Current report, items 4.01 and 9.01 - Sunshine Biopharma Inc. (0001402328) (Filer)

2025-07-25T16:05:30-04:00

SEC
POS AM Form - Post-Effective amendments for registration statement - Sunshine Biopharma Inc. (0001402328) (Filer)

2025-07-02T12:00:00Z

AccessWire
Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

2025-06-12T20:24:12-04:00

SEC
SCHEDULE 13G/A Form - [Amend] Statement of Beneficial Ownership by Certain Investors - Sunshine Biopharma Inc. (0001402328) (Subject)

2025-06-11T12:30:00Z

AccessWire
Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market